Arkolith/Insider Trading/RAIN/Form 4

Vellanki Avanish

Chairman and CEO, DirectorRain Oncology Inc. (RAIN) · full profile →Form 4 · filed Aug 11, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 9, 2023Grant(A)267K—$0267K
Aug 9, 2023Grant(A)133K—$0133K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-090706) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML